Literature DB >> 30549244

Cell-Templated Silica Microparticles with Supported Lipid Bilayers as Artificial Antigen-Presenting Cells for T Cell Activation.

Brynn R Olden1, Caleb R Perez1, Ashley L Wilson2, Ian I Cardle1,2, Yu-Shen Lin1, Bryan Kaehr3, Joshua A Gustafson2, Michael C Jensen2, Suzie H Pun1.   

Abstract

Biomaterial properties that modulate T cell activation, growth, and differentiation are of significant interest in the field of cellular immunotherapy manufacturing. In this work, a new platform technology that allows for the modulation of various activation particle design parameters important for polyclonal T cell activation is presented. Artificial antigen presenting cells (aAPCs) are successfully created using supported lipid bilayers on various cell-templated silica microparticles with defined membrane fluidity and stimulating antibody density. This panel of aAPCs is used to probe the importance of activation particle shape, size, membrane fluidity, and stimulation antibody density on T cell outgrowth and differentiation. All aAPC formulations are able to stimulate T cell growth, and preferentially promote CD8+ T cell growth over CD4+ T cell growth when compared to commercially available pendant antibody-conjugated particles. T cells cultured with HeLa- and red blood cell-templated aAPCs have a less-differentiated and less-exhausted phenotype than those cultured with spherical aAPCs with matched membrane coatings when cultured for 14 days. These results support continued exploration of silica-supported lipid bilayers as an aAPC platform.
© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  T cells; activation; artificial antigen presenting cells; supported lipid bilayers

Year:  2018        PMID: 30549244      PMCID: PMC6394850          DOI: 10.1002/adhm.201801188

Source DB:  PubMed          Journal:  Adv Healthc Mater        ISSN: 2192-2640            Impact factor:   9.933


  26 in total

Review 1.  T cell subsets and their signature cytokines in autoimmune and inflammatory diseases.

Authors:  Itay Raphael; Saisha Nalawade; Todd N Eagar; Thomas G Forsthuber
Journal:  Cytokine       Date:  2014-10-30       Impact factor: 3.861

2.  Mechanically encoded cellular shapes for synthesis of anisotropic mesoporous particles.

Authors:  Kristin C Meyer; Eric N Coker; Dan S Bolintineanu; Bryan Kaehr
Journal:  J Am Chem Soc       Date:  2014-09-10       Impact factor: 15.419

3.  PD-1 blockade modulates chimeric antigen receptor (CAR)-modified T cells: refueling the CAR.

Authors:  Elise A Chong; J Joseph Melenhorst; Simon F Lacey; David E Ambrose; Vanessa Gonzalez; Bruce L Levine; Carl H June; Stephen J Schuster
Journal:  Blood       Date:  2016-12-28       Impact factor: 22.113

4.  Particle shape dependence of CD8+ T cell activation by artificial antigen presenting cells.

Authors:  Joel C Sunshine; Karlo Perica; Jonathan P Schneck; Jordan J Green
Journal:  Biomaterials       Date:  2013-10-05       Impact factor: 12.479

5.  CD28 and CD3 have complementary roles in T-cell traction forces.

Authors:  Keenan T Bashour; Alexander Gondarenko; Haoqian Chen; Keyue Shen; Xin Liu; Morgan Huse; James C Hone; Lance C Kam
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-27       Impact factor: 11.205

6.  Electrostatically mediated liposome fusion and lipid exchange with a nanoparticle-supported bilayer for control of surface charge, drug containment, and delivery.

Authors:  Juewen Liu; Xingmao Jiang; Carlee Ashley; C Jeffrey Brinker
Journal:  J Am Chem Soc       Date:  2009-06-10       Impact factor: 15.419

Review 7.  PD-1 and its ligands in tolerance and immunity.

Authors:  Mary E Keir; Manish J Butte; Gordon J Freeman; Arlene H Sharpe
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

8.  Biodegradable nanoellipsoidal artificial antigen presenting cells for antigen specific T-cell activation.

Authors:  Randall A Meyer; Joel C Sunshine; Karlo Perica; Alyssa K Kosmides; Kent Aje; Jonathan P Schneck; Jordan J Green
Journal:  Small       Date:  2015-01-12       Impact factor: 13.281

Review 9.  Linking form to function: Biophysical aspects of artificial antigen presenting cell design.

Authors:  Karlo Perica; Alyssa K Kosmides; Jonathan P Schneck
Journal:  Biochim Biophys Acta       Date:  2014-09-06

10.  Scaffolds that mimic antigen-presenting cells enable ex vivo expansion of primary T cells.

Authors:  Alexander S Cheung; David K Y Zhang; Sandeep T Koshy; David J Mooney
Journal:  Nat Biotechnol       Date:  2018-01-15       Impact factor: 54.908

View more
  3 in total

1.  Characterization of regulatory T cell expansion for manufacturing cellular immunotherapies.

Authors:  David A McBride; Matthew D Kerr; Shinya L Wai; Yvonne Y Yee; Dora A Ogbonna; Nisarg J Shah
Journal:  Biomater Sci       Date:  2020-05-22       Impact factor: 6.843

Review 2.  Nanoparticles for generating antigen-specific T cells for immunotherapy.

Authors:  Savannah E Est-Witte; Natalie K Livingston; Mary O Omotoso; Jordan J Green; Jonathan P Schneck
Journal:  Semin Immunol       Date:  2021-12-23       Impact factor: 11.130

Review 3.  Polymeric Systems for Cancer Immunotherapy: A Review.

Authors:  Thai Minh Duy Le; A-Rum Yoon; Thavasyappan Thambi; Chae-Ok Yun
Journal:  Front Immunol       Date:  2022-02-22       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.